For BCSClass 1 (high solubility, high permeability) and BCS Class 3 (high solubility,low permeability) compounds, a biowaiver can be granted inlieu of performing a clinical bioequivalence study, provided that additionalcriteria on formulation dissolution and compositional changesare fulfilled.